Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,672 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA; STENT Group. Brodie BR, et al. Among authors: wilson h. JACC Cardiovasc Interv. 2009 Nov;2(11):1105-12. doi: 10.1016/j.jcin.2009.08.020. JACC Cardiovasc Interv. 2009. PMID: 19926052 Free article.
AngioJet experience from the multi-center STENT Registry.
Simonton CA 3rd, Brodie BR, Wilson H, Haber R, Kowalchuk G, Rinaldi M, Cedarholm J, Humphrey A, Laurent S. Simonton CA 3rd, et al. Among authors: wilson h. J Invasive Cardiol. 2006 Jul;18 Suppl C:C22-3. J Invasive Cardiol. 2006. PMID: 16883028
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB, Nikolsky E, Cutlip DE, Mauri L, Liberman H, Wilson H, Patterson J, Moses J, Kandzari DE; ENDEAVOR IV Investigators. Leon MB, et al. Among authors: wilson h. JACC Cardiovasc Interv. 2010 Oct;3(10):1043-50. doi: 10.1016/j.jcin.2010.07.008. JACC Cardiovasc Interv. 2010. PMID: 20965463 Free article. Clinical Trial.
Public Reporting of Mortality After PCI in Cardiac Arrest and Cardiogenic Shock: An Opinion From the Interventional Council and the Board of Governors of the American College of Cardiology.
Rab T; Interventional Council; Wilson H; Board of Governors. Rab T, et al. Among authors: wilson h. JACC Cardiovasc Interv. 2016 Mar 14;9(5):496-8. doi: 10.1016/j.jcin.2015.12.006. JACC Cardiovasc Interv. 2016. PMID: 26965939 Free article. Review. No abstract available.
Clinical Outcomes and Practicality of Transferring Patients Immediately to Originating Hospitals After Primary Percutaneous Coronary Intervention-A Retrospective Study.
Kamaraj S, Firdaus ML, Norfarahdina R, Muizz AMA, Ranga ARA, Henry TD, Wilson H, Glendon LSK, Raqib AGA, Kahar AGA. Kamaraj S, et al. Among authors: wilson h. Catheter Cardiovasc Interv. 2025 Jan;105(1):99-108. doi: 10.1002/ccd.31290. Epub 2024 Nov 15. Catheter Cardiovasc Interv. 2025. PMID: 39548661
2,672 results